Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine hearts

Catheterization and Cardiovascular Interventions

Volumn 48, Issue 4, 1999, Pages 447-453

  Kornowski, Ran ^a   Fuchs, Shmuel ^a   Tio, Fermin O ^b   Pierre, Anthony ^a   Epstein, Stephen E ^a   Leon, Martin B ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Injection; Myocardium; Therapy

Indexed keywords

CREATINE KINASE MB;

ANGIOCARDIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROMAGNETIC FIELD; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HISTOPATHOLOGY; NONHUMAN; SAFETY; SWINE;

ANIMALS; COLORING AGENTS; CORONARY ANGIOGRAPHY; CREATINE KINASE; DRUG DELIVERY SYSTEMS; EVALUATION STUDIES; HEART CATHETERIZATION; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOENZYMES; MYOCARDIUM; SWINE;

EID: 0032706325     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(199912)48:4<447::AID-CCD23>3.0.CO;2-Y     Document Type: Article

References (10)

1. Ben-Haim SA, Osadchy D, Schuster I, Gepstein L, Hayam G, Josephson ME. Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med 1996;2:1393-1395.
2. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation 1997;95: 1611-1622.
3. Kornowski R, Hong MK, Gepstein L, et al. Preliminary animal and clinical experiences using an electro-mechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation 1998;98:1116-1124.
4. Kornowski R, Hong MK, Haudenschild C, Kim WH, Leon MB. Feasibility and safety of percutaneous direct myocardial revascularization using Biosense system in porcine hearts. Coro Art Dis 1998;9:535-540.
5. Kornowski R, Hong MK, Epstein SE, Leon MB. Electro-magnetic guided catheter-based intramyocardial LV injection: a platform for intramyocardial angiogenesis therapy. Circulation 1998;98:I353.
6. Giordano FJ, Ping P, Mckirnan D, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 1996;2:5349.
7. Mack CA, Patel SR, Schwartz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for VEGF-12, improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998;115:168-177.
8. Schumacher B, Pecher P, von Specht BU, Stegman T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 1998;97:645-650.
9. Lazarous DF, Shou M, Stiber JA, et al. Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. Cardiovasc Res 1997;36:78-85.
10. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998;98:2800-2804.